| Issue |
Title |
File |
| No 4 (2016) |
Experience with a drug containing isoflavones used in the correction of psychosomatic disorders in women with climacteric syndrome |
|
|
Chernichenko I.I., Voishnarovich A.V.
|
| No 6 (2023) |
Experience with a modified molded sorbent in the treatment of postpartum endometritis |
|
|
Barinov S.V., Lazareva O.V., Tirskaya Y.I., Kadtsyna T.V., Chulovsky Y.I., Orlitskaya A.D., Leont’eva N.N., Blauman E.S.
|
| No 3 (2017) |
Experience with a V-Loc 180 retaining self-locking suture during laparoscopic myomectomy |
|
|
Chuprynin V.D., Khilkevich E.G., Yazykova O.I., Usacheva V.V., Melnikov M.V., Veredchenko A.V., Burykina P.N., Chursin V.V.
|
| No 6 (2014) |
EXPERIENCE WITH ALLOKIN-ALPHA IN THE TREATMENT OF HUMAN PAPILLOMAVIRUS-ASSOCIATED DISEASES |
|
|
DOVLETKHANOVA E.R., PRILEPSKAYA V.N., ABAKAROVA P.R., MEZHEVITINOVA E.A.
|
| No 4 (2008) |
Experience with an Elton Lake therapeutic mud lipid fraction used in the complex treatment of cervicitis |
|
|
Zharkin N.A., Shchetinina T.A.
|
| No 5 (2023) |
Experience with bovhyaluronidase azoximer used in the combination treatment of chronic endometritis in women with repeated implantation failures |
|
|
Lokshin V.N., Askar Y., Rybina A.N., Abshekenova A.T., Karibayeva S.K., Valiev R.K.
|
| No 7 (2015) |
Experience with carbetocin for preventing hypotonic hemorrhage |
|
|
Kurtser M.A., Kutakova J.J., Spiridonova E.I., Cherepnina A.L., Balitsky S.P.
|
| No 11 (2020) |
Experience with clotrimazole 2% cream in the therapy of vulvovaginal candidiasis: results of observational study |
|
|
Rakhmatulina M.R., Tarasenko E.N., Bolshenko N.V.
|
| No 8 (2011) |
EXPERIENCE WITH COMBINATION TREATMENT FOR GENITAL HERPES IN WOMEN |
|
|
UDZHUKHU V.Y.
|
| No 5 (2016) |
EXPERIENCE WITH COMBINATION VAGINAL AGENTS USED IN THE TREATMENT OF MIXED VAGINOSIS/VAGINITIS IN POSTMENOPAUSAL WOMEN |
|
|
Aivazova D.S.
|
| No 2 (2019) |
Experience with different cholecalciferol dosing regimens to achieve adequate levels in patients with reproductive dysfunction |
|
|
Chikh E.V., Tikhomirov S.V., Zaitseva T.A., Segedina E.M., Treivish L.S.
|
| No 2 (2012) |
EXPERIENCE WITH EFFERENT METHODS USED IN THE TREATMENT OF SEVERE HYPERLIPIDEMIA IN A PREGNANT WOMAN |
|
|
FEDOROVA T.A., ROGACHEVSKY O.V., ORDZHONIKIDZE N.V., TKACHEVA O.N., MITRYA I.V.
|
| No 4 (2008) |
Experience with focused ultrasound ablation used in uterine leiomyoma |
|
|
Sukhikh G.T., Samoilova T.Y., Maksutova D.Z., Kurinov S.B., Kulabukhova Y.A., Smetnik V.P., Volobayev A.I.
|
| No 5 (2012) |
EXPERIENCE WITH GANCICLOVIR IN THE TREATMENT OF THE GENERALIZED FORM OF CYTOMEGALOVIRUS INFECTION |
|
|
DEGTYAREVA A.V., ZUBKOV V.V., NEPSHA O.S., BURMENSKAYA O.V., LACHINYAN V.L., DONNIKOV A.E., MILAYA O.V., DEGTYAREV D.N.
|
| No 7 (2022) |
EXPERIENCE WITH GINGER IN THE TREATMENT OF NAUSEA AND VOMITING OF PREGNANCY |
|
|
KHABAROV S.V.
|
| No 12 (2013) |
EXPERIENCE WITH GLYCYRRIZIC ACID USED IN BENIGN CHANGES IN THE CERVIX UTERI |
|
|
TKACHENKO L.V., KRAPIVINA M.A.
|
| No 12 (2014) |
Experience with gynestril in the treatment of patients with uterine myoma |
|
|
Levakov S.A., Kedrova A.G., Nechaeva O.E., Vanke N.S., Chelnokova N.N., Levakova S.E.
|
| No 9 (2013) |
EXPERIENCE WITH HAEMONETICS CELL SAVER 5+ IN OBSTERIC PRACTICE |
|
|
SAVELYEVA G.M., KURTSER M.A., BRESLAV I.Y., BREUSENKO L.E., LATYSHKEVICH O.A., SHABNITSKY A.M.
|
| No 2 (2017) |
Experience with indole-3-carbinol used to treat diseases of the breast and to prevent breast cancer |
|
|
Smetnik A.A., Smetnik V.P., Kiselev V.I.
|
| No 12 (2018) |
Experience with interferon-gamma in the therapy of sexually transmitted viral infections |
|
|
Rakhmatulina M.R., Bolshenko N.V.
|
| No 11 (2021) |
Experience with Intralipid in early reproductive losses |
|
|
Bespalova O.N., Zhernakova T.S.
|
| No 11 (2020) |
Experience with intrauterine plateletrich plasma infusions for endometrial preparation in thawed embryo transfer programs in patients with an unfavorable prognosis of treatment outcomes |
|
|
Savina V.A., Samoilovich Y.A., Isakova E.V.
|
| No 8 (2013) |
EXPERIENCE WITH INVASIVE CORRECTION OF FETOFETAL TRANSFUSION SYNDROME |
|
|
KOSOVTSOVA N.V., BASHMAKOVA N.V., KOVALEV V.V., MARKOVA T.V., POTAPOV N.N.
|
| No 12 (2019) |
Experience with laser Doppler flowmetry in the evaluation of hemodynamic disorders of microcirculation in the fetoplacental complex |
|
|
Gadzhieva P.K., Dikareva L.V.
|
| No 7 (2021) |
Experience with micronized progesterone in obstetric practice |
|
|
Khodzhaeva Z.S., Klimenchenko N.I., Muminova K.T., Gorina K.A., Frankevich V.E.
|
| No 5 (2015) |
EXPERIENCE WITH MICRONIZED PROGESTERONE THERAPY FOR MISCARRIAGE IN PREGNANT WOMEN WITH UTERINE MYOMA |
|
|
Iashchuk A.G., Dautova L.A., Shevchenko Y.R., Naftulovich R.A., Tyurina A.A., Murzin V.R.
|
| No 9 (2014) |
Experience with micronized progesterone used in combined hormone therapy in periand postmenopausal women |
|
|
Yarmolinskaya M.I.
|
| No 8 (2011) |
EXPERIENCE WITH ORGAN-SPARING SURGERY FOR PLACENTA ACCRETA |
|
|
KURTSER M.A., BRESLAV I.Y., LUKASHINA M.V., SHTABNITSKY A.M., PANIN A.V., ALEKSEYEVA T.V., PLATITSIN I.V.
|
| No 6 (2016) |
Experience with oxytocin receptor antagonist for incipient preterm labor |
|
|
Fatkullin I.F., Fatkullin F.I., Munavirova A.A., Islamova L.H., Akhmetgaliev A.R., Shaikhetdinova A.T.
|
| No 4-2 (2012) |
EXPERIENCE WITH PREGNANCY AND CHILDBIRTH MANAGEMENT IN PATIENTS WITH INFLUENZA A (H1N1) |
|
|
KURTSER M.A., KALINOVSKAYA I.I., MALYSHEV N.A., SEROBYAN A.G., KELLI E.I., KUTAKOVA Y.Y., CHEREPNINA A.L.
|
| No 9 (2018) |
Experience with sanitary products containing the probiotic strain Lactobacillus acidophilus in reproductive-aged and postmenopausal women for the prevention of opportunistic vaginal infections |
|
|
Lyubasovskaya L.A., Melkumyan A.R., Dubodelov D.V., Rodchenko Y.V., Muravyeva V.V., Kondrakhin A.P., Maikova G.B., Amirkhanyan A.S., Nikolaeva N.V., Bairamova G.R., Priputnevich T.V.
|
| No 5 (2012) |
EXPERIENCE WITH SPONTANEOUS DELIVERY IN WOMEN WITH A UTERINE SCAR AFTER MYOMECTOMY |
|
|
PEKAREV O.G., MAIBORODIN I.V., PEKAREVA E.O., POZDNYAKOV I.M., POPOVA S.P.
|
| No 2 (2023) |
Experience with surgery for adenomyosis and assessment of reproductive outcomes |
|
|
Bezhenar V.F., Krylov K.Y., Makarenko T.A., Matukhin V.I., Rukhliada N.N., Tskhay V.B.
|
| No 7 (2013) |
EXPERIENCE WITH TEMPORARY BALLOON OCCLUSION OF THE COMMON ILIAC ARTERIES IN PATIENTS WITH PLACENTA INCRETA DURING ORGAN-SPARING OPERATIONS |
|
|
KURTSER M.A., BRESLAV I.Y., GRIGORYAN A.M., LATYSHKEVICH O.A.
|
| No 9 (2021) |
Experience with the natural non-hormonal drug Serelis in the therapy of menopausal syndrome in surgical menopausal women |
|
|
Gavrilov M.V., Puchkina G.A., Ermolenko N.S., Simacheva S.A., Sulima A.N.
|
| No 6 (2021) |
Experience with the vitamin-mineral complex “Pregnomama” in women with physiological pregnancy |
|
|
Gromova O.A., Pesegova E.V., Torshin I.Y., Tetruashvili N.K.
|
| No 3 (2016) |
EXPERIENCE WITH ULIPRISTAL ACETATE IN PATIENTS WITH UTERINE MYOMA |
|
|
Podzolkova N.M., Puchkov K.V., Korennaya V.V.
|
| No 11 (2020) |
Experience with ultrasonic cavitation in patients with chronic endometritis before IVF |
|
|
Khabarov S.V., Gorskaya O.S., Rusanova G.P.
|
| No 3 (2018) |
Experience with uterine balloon tamponade in postpartum hypotonic bleedings |
|
|
Askerov A.A., Nazaralieva S.B., Osmonova S.K.
|
| No 7 (2016) |
Experience with vaginal and uterine catheters Zhukovskiy and a topical hemostatic agent in the treatment of postpartum bleeding during cesarean section |
|
|
Barinov S.V., Zhukovskiy Y.G., Medyannikova I.V., Shavkun I.A., Zhilin A.V., Razdobedina I.N., Grebenyuk O.A., Kovaleva Y.A.
|
| No 5 (2016) |
EXPERIMENTAL RATIONALE FOR THE ENDOTHELIAL PROTECTIVE EFFECT OF INTRAVENOUS IMMUNOGLOBULINS IN OBSTETRIC DISEASE |
|
|
Chepanov S.V., Sokolov D.I., Shlachtenko T.N., Kapustin R.V., Okorokova L.S., Belyakova K.L., Selkov S.A.
|
| No 8 (2016) |
Experimental rationale for the use of cell technologies for the correction of myometrial scar |
|
|
Pekarev O.G., Maiborodin I.V., Pozdnyakov I.M., Onoprienko N.V., Pekareva E.O., Anikeev A.A.
|
| No 9 (2022) |
Experimental technique for the transfer of pronuclear stage genetic material |
|
|
Sukhikh G.T., Kamaletdinov N.S., Nazarenko T.A., Martirosyan Y.O.
|
| No 4 (2020) |
Expert Council Resolution on Prevention and Treatment of Iron Deficiency Anemia in Pregnant Women |
|
|
- -.
|
| No 1 (2013) |
EXPRESSION OF APOPTOSIS-REGULATORY GENES IN DIFFERENT ENDOMETRIAL HYPERPLASIA TYPES AND ENDOMETRIOID CARCINOMA |
|
|
CHERNUKHA G.E., DUMANOVSKAYA M.R., BURMENSKAYA O.V., SHUBINA E.S., KOGAN E.A., TROFIMOV D.Y.
|
| No 7 (2023) |
Expression of ephrin receptor A1 on the membrane of epitheliocyte glands of the uterine mucosa in patients with endometrial cancer and endometriosis |
|
|
Muftaydinova S.K., Senina D.N., Litvinova V.V., Fayzullina N.M., Asaturova A.V., Buralkina N.A., Ovodenko D.L., Fayzullin L.Z., Chuprynin V.D.
|
| No 6 (2022) |
Expression of ephrin receptor A3 in glandular epithelial cells of uterine endometrium in patients with endometriosis and endometrial cancer |
|
|
Chuprynin V.D., Muftaydinova S.K., Senina D.N., Fayzullina N.M., Asaturova A.V., Buralkina N.A., Fayzullin L.Z., Ovodenko D.L., Kozachenko A.V.
|
| No 3 (2022) |
Expression of exosomal microRNA in high-grade ovarian cancer and ovarian endometriotic cysts |
|
|
Iurova M.V., Eldarov C.M., Bobrov M.Y., Khabas G.N., Pavlovich S.V.
|
| No 9 (2016) |
EXPRESSION OF MESENCHYMAL CELLULAR MARKERS IN THE ENDOMETRIUM IN HEALTH AND IN PROLIFERATIVE UTERINE DISEASES |
|
|
Anikina T.A., Sysoeva V.Y., Rubina K.A., Radzinsky V.E.
|
| No 9 (2013) |
EXPRESSION OF VIRAL ONCOGENES P16 AND KI67 AND VIRAL LOAD IN DIFFERENT TYPES OF UROGENITAL PAPILLOMAVIRUS INFECTION |
|
|
EVSTIGNEEVA N.P., KUZNETSOVA Y.N., BALBERT N.A., POTAPOVA A.L., MEDVEDEVA Y.A.
|
| No 11 (2019) |
Expression of vitamin d and its receptors in the villous chorion in missed miscarriage |
|
|
Bespalova O.N., Bakleicheva M.O., Kovaleva I.V., Tolibova G.K., Tral T.G., Kogan I.Y.
|
| No 2 (2024) |
Expression patterns of maternal and fetal tissue and exosomal microRNAs during pre-induction of labor (pilot study) |
|
|
Gaidarova A.R., Gusar V.A., Chagovets V.V., Kan N.E., Edilberg I.V., Baev O.R.
|
| No 2 (2012) |
EXPRESSIONS OF PERITONEAL MACROPHAGE SCAVENGER RECEPTORS IN EXTERNAL GENITAL ENDOMETRIOSIS |
|
|
ANTSIFEROVA Y.S., POSISEYEVA L.V., SOTNIKOVA N.Y., ELISEYEVA M.A.
|
| No 11 (2019) |
External cephalic version in cases of pelvic and transverse lie |
|
|
Semenova E.R.
|
| No 1 (2024) |
Extracellular vesicles derived from multipotent mesenchymal stromal cells: pathogenetic rationale for therapeutic use |
|
|
Martirosyan Y.O., Kadaeva A.I., Silachev D.N., Nazarenko T.A., Matveeva P.V.
|
| No 6 (2023) |
Extracellular vesicles in follicular fluid: clinical aspects and molecular biology |
|
|
Dovgan A.A., Akhmedova Z.F., Sysoeva A.P., Zingerenko B.V., Romanov E.A., Silachev D.N., Makarova N.P., Kalinina E.A.
|
| No 4-2 (2012) |
EXTRAGENITAL DISEASES AND THE SOCIAL STATUS OF WOMEN WITH SPONTANEOUS ABORTION |
|
|
MEDVEDEV B.I., VOROPAYEVA E.E., KAZACHKOV E.L., KAZACHKOVA E.A.
|
| No 1 (2015) |
Extragenital diseases as a cause of maternal death |
|
|
Shuvalova M.P., Frolova O.G., Grebennik T.K., Ratushnyak S.S., Guseva E.V.
|
| No 8 (2022) |
Extragenital endometriosis: diagnostic difficulties, modern treatment policy |
|
|
Yarmolinskaya M.I., Rusina E.I., Semenova V.O., Beganova A.K.
|
| No 10 (2018) |
Extragenital sexually transmitted infections: epidemiology, clinical presentations, diagnosis, and therapy |
|
|
Rakhmatulina M.R., Bolshenko N.V.
|
| No 6 (2022) |
Extramammary Paget’s disease |
|
|
Grekova Y.N., Zilberberg N.V., Kuznetsova E.I.
|
| No 9 (2020) |
Extraperitoneal cesarean section: the place of the operation in the world and in Russian obstetrics |
|
|
Krasnopolsky V.I., Melnikov A.P., Petrukhin V.A., Karamyan R.A.
|
| No 2 (2016) |
Extraplacental trophoblast structures: Study, structure, functions, properties, diagnostic and therapeutic value |
|
|
Prokopyuk V.Y.
|
| No 7 (2014) |
EXTREMELY PRETERM BIRTHS IN THE URAL FEDERAL DISTRICT: PROBLEMS AND PROSPECTS |
|
|
Bashmakova N.V., Malygina G.B., Litvinova A.M.
|
| No 5 (2019) |
Factors influencing the participation of women in cervical cancer screening programs |
|
|
Apolikhina I.A., Bashirova L.K., Gasanova G.F.
|
| No 9 (2023) |
Factors regulating placental angio/vasculogenesis in complications of pregnancy and childbirth |
|
|
Khomyakova E.V., Ziganshina M.M., Baev O.R.
|
| No 10 (2019) |
Fast track in gynecology: today’s realities |
|
|
Torubarov S.F., Dukhin A.O., Chmur E.N.
|
| No 6S (2019): Supplement |
FAST-TRACK KhIRURGIYa. STATsIONARNYY ETAP |
|
|
Lisovskaya E.V., Chuprynin V.D., Khil'kevich E.G., Mel'nikov M.V.
|
| No 5 (2022) |
Favorable maternal and perinatal outcomes of pregnancy in a COVID-19 patient with total lung damage |
|
|
Tezikov Y.V., Tezikova T.A., Lipatov I.S., Nechayeva M.V., Yakusheva A.O., Tyutyunnik V.L., Kan N.E.
|
| No 4 (2021) |
Favorable outcome of managing a pregnant woman with epidermolytic drug syndrome |
|
|
Tezikov Y.V., Tezikova T.A., Lipatov I.S., Shmakov R.G., Rakitina V.N., Mishina E.A.
|
| No 10 (2021) |
Favorable outcome of the extremely severe course of the new coronavirus infection COVID-19 during pregnancy in the presence of overall lung damage, acute myocarditis, and myocardial infarction |
|
|
Voropaeva E.E., Ishchenko L.S., Mikhailova S.A., Aleksandrov D.I., Khaidukova Y.V., Kazachkova E.A., Kazachkov E.L.
|
| No 4 (2022) |
Feasibility of delivery in patients receiving mesenchymal stromal cell-derived extracellular microvesicles during the previous caesarean section |
|
|
Sukhikh G.T., Pekareva E.O., Pekarev O.G., Silachev D.N., Maiborodin I.V., Baranov I.I., Pozdnyakov I.M., Bushueva N.S.
|
| No 6 (2018) |
Feasibility of objective assessment of the progress of preterm labor at different gestational ages |
|
|
Novikova V.A., Cherepakhin E.P., Glebova E.V., Nikonov M.A., Tomashevsky D.V.
|
| No 2 (2023) |
Feasibility of predicting fetal growth restriction, by identifying plasma biomarkers |
|
|
Izhoykina E.V., Trifonova E.A., Kutsenko I.G., Stepanov I.A., Gavrilenko M.M., Stepanov V.A.
|
| No 1 (2023) |
Feasibility of preimplantation genetic testing for aneuploidy in patients undergoing in vitro fertilization after conservative treatment of atypical hyperplasia and early endometrial cancer |
|
|
Krasnopolskaya K.V., Novikova O.V., Isakova K.M., Shostenko L.V., Rau D.I., Shishkina A.V.
|
| No 9 (2021) |
Feasibility of using long noncoding RNAs for predicting malignant transformation of cervical epithelium |
|
|
Levakov S.A., Obukhova E.A., Sheshukova N.A., Bol'shakova O.V., Shakhparonov M.I., Antipova N.V.
|
| No 10 (2021) |
Features of changes in the monocyte-macrophage cells in the placenta during preeclampsia |
|
|
Boris D.A., Tyutyunnik V.L., Kan N.E., Shchegolev A.I., Sinitsyna V.A., Sadekova A.A., Krasnyi A.M.
|
| No 1 (2013) |
FEATURES OF COGNITIVE PERFORMANCE IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION |
|
|
RUNIKHINA A.N., SHARASHKINA N.V., LARINA V.N., BART B.Y.
|
| No 10 (2019) |
Features of correction of the immune status in the therapy of infectious and inflammatory diseases of the reproductive system |
|
|
Khashukoeva A.Z., Ilyina I.Y., Agaeva Z.A., Agaeva M.I., Khlynova S.A.
|
| No 1 (2021) |
FEATURES OF ELECTIVE MEDICAL CARE PROVIDED TO PATIENTS WITH GYNECOLOGICAL DISEASES UNDER CONDITIONS OF A RISK FOR SPREADING THE NOVEL CORONAVIRUS INFECTION. EXPERIENCE OF THE URALS REGION |
|
|
MALGINA G.B., MIKHELSON A.A., MELKOZEROVA O.A., OKULOVA E.O., LAZUKINA M.V., LUKACH M.A., MINYAYLO E.M.
|
| No 9 (2021) |
Features of endometrial tissue metabolism of androgens: a modern view |
|
|
Gavisova A.A., Shevtsova M.A., Tskhovrebova L.T.
|
| No 1 (2020) |
Features of formation of the activity-dormancy cycle in fetuses with growth restriction and developmental delay |
|
|
Pavlova N.G., Dyusembinova S.D.
|
| No 10 (2018) |
Features of formation of the fetoplacental complex following transfer of fresh and vitrified embryos in in vitro fertilization programs |
|
|
Shumovskaya V.V., Putilova N.V., Mazurov D.O.
|
| No 9 (2015) |
Features of functional state of the mitochondrial apparatus in overweight and obese women in IVF programs |
|
|
Smolnikova V.Y., Gorshinova V.K., Volodina M.A., Tarasova N.V., Vysokikh M.Y., Kalinina E.A.
|
| No 6 (2022) |
Features of interaction of Toll-like receptors with virus infection of the reproductive tract as a predictor of chronic endometritis |
|
|
Ievleva K.D., Danusevich I.N., Suturina L.V.
|
| No 1 (2020) |
Features of karyotypes in married couples with reproductive functional problems in Kazakhstan |
|
|
Khoroshilova I.G., Lokshin V.N., Begimbaeva A.A., Sarsenbaeva Z.K., Valiev R.K., Rybina A.N., Karibaeva S.K., Kim A.V., Semenova N.Y.
|
| No 2 (2018) |
Features of medical care for gestational diabetes mellitus (in case of a specialized obstetric hospital) |
|
|
Radzinsky V.E., Papysheva O.V., Esipova L.N., Startseva N.M., Kotaish G.A.
|
| No 6 (2020) |
Features of micronutrient preparation for pregnancy in women with polycystic ovary syndrome |
|
|
Kuznetsova I.V., Gavrilova E.A.
|
| No 3 (2022) |
Features of modern obstetrics |
|
|
Serov V.N., Nesterova L.A.
|
| No 11 (2022) |
Features of neurogenesis in fetal growth restriction |
|
|
Kan N.E., Leonova A.A., Tyutyunnik V.L., Khachatryan Z.V.
|
| No 12 (2013) |
FEATURES OF REPRODUCTIVE BEHAVIOR OF YOUNG PEOPLE |
|
|
DIKKE G.B., EROFEEVA L.V.
|
| No 11 (2017) |
Features of reproductive function realization in HIV-infected women |
|
|
Selimova F.N., Perminova S.G., Mityurina E.V., Kozyrina N.V.
|
| No 10 (2017) |
Features of reproductive function realization in women with infertility and HIV infection in assisted reproductive technology programs |
|
|
Mityurina E.V., Perminova S.G., Selimova F.N., Kozyrina N.V., Abubakirov A.N.
|
| No 12 (2019) |
Features of serum lipidome in pregnant women with fetal macrosomia and a concurrence of macrosomia with gestational diabetes mellitus |
|
|
Odinokova V.A., Chagovets V.V., Shmakov R.G., Starodubtseva N.L., Salimova D.F., Kononikhin A.S., Frankevich V.E.
|
| No 6 (2017) |
FEATURES OF SOME VASOACTIVE HORMONES AND VASCULAR FACTORS IN WOMEN WITH METABOLIC SYNDROME AND THEIR INFLUENCE ON THE DEVELOPMENT OF OBSTETRIC COMPLICATIONS |
|
|
Palieva N.V., Botasheva T.L., Linde V.A., Avrutskaya V.V., Zheleznyakova E.V.
|
| No 5 (2019) |
Features of the cervical canal microbiota in prenatal amniorrhea and full-term pregnancy |
|
|
Kaganova M.A., Spiridonova N.V., Kazakova A.V., Devyatova O.O., Galkina D.A., Golovina O.N.
|
| No 12 (2017) |
Features of the composition of peripheral blood lymphocyte subpopulations with cytotoxic, killer, and regulatory functions in women with recurrent implantation failures in ART programs |
|
|
Amyan T.S., Krechetova L.V., Perminova S.G., Vtorushina V.V.
|
| No 11 (2016) |
FEATURES OF THE ENDOTHELIAL FUNCTIONAL STATE AND THE FEASIBILITY OF ITS CORRECTION IN PREMATURE OVARIAN FAILURE |
|
|
Pozdnyakova A.A., Sharashkina N.V., Ivanets T.Y., Butareva L.B., Runikhina N.K., Marchenko L.A.
|
| No 9 (2018) |
Features of the expression of the immunohistochemical markers P16 and KI67 in women with chronic cervicitis associated with bacterial and viral infections |
|
|
Bokach O.M., Niauri D.A., Tishkov A.V., Selkov S.A.
|
| No 4 (2018) |
Features of the myometrial status during cesarean section with regard to amniorrhea and birth activity: A clinical and morphological study |
|
|
Prikhodko A.M., Baev O.R., Karapetyan A.O., Demura T.A., Kogan E.A.
|
| No 8 (2019) |
FEATURES OF THE PROFILE OF PROTEINS SECRETED BY CELLS FROM THE ENDOMETRIOID FOCI AND EUTOPIC ENDOMETRIUM IN WOMEN WITH EXTERNAL GENITAL ENDOMETRIOSIS IN IN VITRO CULTURE |
|
|
PavlovichStanislav V.V., Krechetova L.V., Vtorushina V.V., Vanko L.V., Yushina M.N., Savilova A.M., MakiyanZograb N.N., Yarotskaya E.L., Khilkevich E.G., Chuprynin V.D., Sykhikh G.T.
|
| No 6 (2011) |
FEMALE COUNSELING AS AN IMPORTANT TOOL WHEN INDIVIDUALLY CHOOSING A CONTRACEPTIVE METHOD |
|
|
ALESINA I.L.
|
| No 3 (2021) |
Female genital microbiota: health, pathology, ways of correction |
|
|
Punchenko O.E., Bereznitskaya E.A., Ermolenko E.I.
|
| No 3 (2009) |
Female genital prolapse: etiology and pathogenesis |
|
|
Bakhaev V.V., Gorin V.S., Bakhayev V.V., Gorin V.S.
|
| No 3 (2014) |
FEMALE LIBIDO PROBLEMS AND HORMONAL CONTRACEPTION |
|
|
FEDOROVA A.I.
|
| No 9 (2013) |
FEMALE REPRODUCTIVE ORGAN CANCER: MORBIDITY TRENDS IN THE PRIMORYE TERRITORY (1992-2011) |
|
|
PISAREVA L.F., BOYARKINA A.P., ODINTSOVA I.N., GURINA L.I., VOLKOV M.V.
|
| No 3 (2014) |
FEMALE REPRODUCTIVE SYSTEM AGING: FROM THEORY TO CLINICAL PRACTICE PART 1. THE ENDOCRINE AND CLINICAL CHARACTERISTICS OF FEMALE REPRODUCTIVE SYSTEM AGING STAGES |
|
|
Yureneva S.V., Ilyina L.M., Smetnik V.P.
|
| No 4 (2014) |
Female reproductive system aging: From theory to clinical practice. Part 2. Role of hormone therapy in solving the problems of transition stage and early postmenopause |
|
|
Yureneva S.V., Ilyina L.M.
|
| No 4 (2010) |
Ferric(III)-hydroxide saccharose complex (venofer): experience of its use in obstetric and pediatric gynecological practice |
|
|
Adamyan L.V., Smol'nova T.Y., Sibirskaya E.V., Adamyan L.V., Smolnova T.Y., Sibirskaya Y.V.
|
| No 7 (2014) |
FERTILITY FOLLOWING DISCONTINUATION OF HORMONAL CONTRACEPTION |
|
|
Tarasova M.A., Shapovalova K.A.
|
| No 11 (2021) |
Fertility outcomes in women after therapy for non-Hodgkin lymphoma |
|
|
Dmitrieva I.Y., Nazarenko T.A., Burduli A.G., Polushkina E.S., Khokhlova S.V.
|
| No 4 (2020) |
Fertility preservation in patients diagnosed with cancer during pregnanc |
|
|
Kirillova A.O., Bunyaeva E.S., Koval’skaya E.V., Kamaletdinov N.S., Khabas G.N., Farmakovskaya M.D., Sirotkina E.A., Mishieva N.G., Nazarenko T.A., Abubakirov A.N.
|
| No 4 (2020) |
Fertility preservation in patients with primary brain tumors |
|
|
Ladimirova I.V., Kalinina E.A., Nazarenko T.A., Astafyeva L.I., Sharipov O.I., Kalinin P.L.
|
| No 1 (2022) |
Fertility preservation in women with placenta accreta spectrum undergoing organsparing surgery |
|
|
Mikheeva A.A., Shmakov R.G., Rogachevskiy O.V., Yarygina T.A., Nizyaeva N.V., Amiraslanov E.Y.
|
| No 2 (2012) |
FERTILITY RECOVERY IN WOMEN WITH GENITAL ENDOMETRIOSIS |
|
|
KUZNETSOVA I.V., KHOVRINA E.A., KIRPIKOV A.S.
|
| No 3 (2021) |
Fetal adaptation to cardiotocography as a criterion of fetal condition |
|
|
Loginov V.V., Davydov D.G., Prikhod'ko A.M., Baev O.R., Degtyarev D.N.
|
| No 1 (2021) |
FETAL BRADYARRYTHMIA IN OBSTETRIC PRACTICE: DIAGNOSIS, POSSIBILITIES FOR THERAPEUTIC APPROACHES, AND PREVENTION |
|
|
POTAPOVA A.A., TIMOSHINA I.V., KHODZHAEVA Z.S., BOCKERIA E.L.
|
| No 6 (2023) |
Fetal cardiotocography in childbirth |
|
|
Istomina N.G., Baranov A.N., Dolidze M.Y.
|
| No 4 (2014) |
Fetal congenital diaphragmatic hernia: ultrasound diagnosis possibilities and prediction of postnatal outcome |
|
|
Demidov V.N., Mashinets N.V., Podurovskaya U.L., Burov A.A.
|
| No 2 (2016) |
Fetal diaphragmatic hernia: Diagnosis, treatment, postnatal outcomes |
|
|
Mashinets N.V.
|
| No 6 (2018) |
Fetal growth restriction and markers for mitochondrial dysfunction |
|
|
Vishnyakova P.A., Sukhanova I.A., Mikaelyan A.G., Bulatova Y.S., Pyataeva S.V., Balashov I.S., Borovikov P.I., Tetruashvili N.K., Vyssokikh M.Y.
|
| No 1 (2024) |
Fetal growth restriction in the rare co-occurrence of chromosomal and monogenic diseases |
|
|
Bolshakova A.S., Barkov I.Y., Frankevich N.A., Yarygina T.A., Shmakov R.G.
|
| No 12 (2020) |
Fetal growth restriction (retardation): everything the practitioner should know |
|
|
Yarygina T.A., Gus A.I.
|
| No 3 (2024) |
Fetal growth retardation as a predictor of health during the future life |
|
|
Gumeniuk E.G., Ivshin A.A., Svetova K.S.
|
| No 8 (2022) |
Fetal growth retardation in the context of fetal programming |
|
|
Soldatova E.E., Kan N.E., Tyutyunnik V.L., Volochaeva M.V.
|
| No 5 (2011) |
FETAL GROWTH RETARDATION: DIAGNOSIS AND AN OPTIMAL DELIVERY METHOD |
|
|
PALADI G., ILIADI-TULBURE K., TABUIKA U.G.
|
| No 10 (2020) |
Fetal lymphangiomas of various locations. The Center’s 14-year experience |
|
|
Mashinets N.V., Demidov V.N., Dorofeeva E.I., Podurovskaya Y.L., Panin A.P., Nikiforov D.V., Filippova E.A., Kulabukhova E.A.
|
| No 2 (2012) |
FETAL MACERATION |
|
|
PAVLOV K.A., DUBOVA E.A., BURDULI G.M., TALALAYEV A.G., SHCHEGOLEV A.I.
|
| No 1 (2018) |
FETAL MACROSOMIA: PREDICTION, PREVENTION, AND TACTICS FOR MANAGEMENT OF PREGNANCY AND DELIVERY |
|
|
Odinokova V.A., Shmakov R.G., Chagovec V.V.
|
| No 11 (2015) |
FETAL MECONIUM PERITONITIS: ULTRASOUND DIAGNOSIS AND OUTCOMES |
|
|
Mashinets N.V., Demidov V.N.
|
| No 11 (2018) |
Fetal mosaicism as a cause of false-negative noninvasive prenatal DNA screening for chromosome 21 aneuploidies |
|
|
Shubina J., Barkov I.Y., Stupko O.K., Kuznetsova M.V., Krasheninnikova R.V., Kim L.V., Tetruashvili N.K., Goltsov A.Y., Kochetkova T.O., Mukosey I.S., Karetnikova N.A., Bakharev V.A., Trofimov D.Y.
|
| No 3 (2018) |
Fetal programming |
|
|
Dzhobava E.M.
|
| No 2 (2023) |
Fetal sacrococcygeal teratoma: new about an old problem |
|
|
Kadyrberdieva F.Z., Syrkashev E.M., Kostyukov K.V., Shmakov R.G.
|
| No 9 (2020) |
Fetal sex in the development of gestational diabetes mellitus and endothelial dysfunction |
|
|
Botasheva T.L., Palieva N.V., Khloponina A.V., Vasiljeva V.V., Zheleznyakova E.V., Zavodnov O.P., Gudz E.B.
|
| No 4 (2009) |
Fetal traumatic damages at cesarean delivery and measures of their prevention |
|
|
Chernukha E.A., Komissarova L.M., Anan'ev E.V., Chernukha Y.A., Komissarova L.M., Ananyev Y.V.
|
| No 10 (2013) |
FETO-FETAL TRANSFUSION SYNDROME. FETOSCOPIC LASER COAGULATION OF ANASTOMOSES |
|
|
BUGERENKO A.E., KURTSER M.A., SICHINAVA L.G., SUKHANOVA D.I.
|
| No 6 (2010) |
FETOPLACENTAL ANGIOGENESIS DURING NORMAL PREGNANCY: A ROLE OF PLACENTAL GROWTH FACTOR AND ANGIOPOIETINS |
|
|
PAVLOV K.A., DUBOVA E.A., ShchEGOLEV A.I., Pavlov K.A., Dubova Y.A., Shchegolev A.I.
|
| No 3 (2011) |
FETOPLACENTAL ANGIOGENESIS DURING NORMAL PREGNANCY: A ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR |
|
|
PAVLOV K.A., DUBOVA E.A., SHCHEGOLEV A.I.
|
| No 9 (2020) |
Fibrin monomer and D-dimer in infertile women undergoing assisted reproductive technology |
|
|
Godzoeva A.O., Zazerskaya I.E., Vlasov V.S., Vavilova T.V., Gorelova I.V., Kustarov V.N., Zhambalova T.V.
|
| No 12 (2018) |
Fifty years of rhesus-immunization immunoprophylaxis: on guard of perinatal morbidity and infant mortality |
|
|
Savelyeva G.M., Kurtser M.A., Sichinava L.G., Konoplyannikov A.G., Latyshkevich O.A., Songolova E.N.
|
| No 4 (2020) |
First experience of autologous platelet rich plasma injection into the endometrium in patients with uterine factor infertility |
|
|
Efendieva Z.N., Apolikhina I.A., Kalinina E.A., Fedorova T.A., Bakuridze E.M., Belousov D.M., Fathudinov T.K., Sukhikh G.T.
|
| No 7 (2019) |
First experience with temporal aortic balloon occlusion in Russian obstetric practice |
|
|
Malgina G.B., Kayumova A.V., Kardapoltsev L.V., Kochmashev I.V., Klimusheva N.F., Erofeev E.N., Zyryanov M.N., Polyanin D.V., Makarov R.A.
|
| No 8 (2018) |
FIRST TRIMESTER PREDICTION OF PREECLAMPSIA BASED ON MATERNAL FACTORS, BIOMARKERS AND 3D POWER DOPPLER OF PLACENTAL BED VASCULARIZATION |
|
|
Kholin A.M., Muminova K.T., Mukhamedovich N.T., Khodzhaeva Z.S., Gus A.I.
|
| No 5 (2021) |
First-line hormone treatment for endometriosis |
|
|
Tikhomirov A.L.
|
| No 8 (2017) |
First-trimester prediction of preeclampsia: Validation of screening algorithms in a Russian population |
|
|
Kholin A.M., Muminova K.T., Balashov I.S., Khodzhaeva Z.S., Borovikov P.I., Ivanets T.Y., Gus A.I.
|
| No 9 (2019) |
Five-year use of robotic surgery in operative gynecology: summary and prospects |
|
|
Krasnopolsky V.I., Popov A.A., Krasnopolskaya K.V., Fedorov A.A.
|
| No 8 (2011) |
FLUORESCENCE DIAGNOSIS AND PHOTODYNAMIC THERAPY FOR VULVAR CONDYLOMATA ACUMINATA |
|
|
DENISOVA E.D., APOLIKHINA I.A., BULGAKOVA N.N.
|
| No 3 (2010) |
Fluorescence diagnosis and photodynamic therapy: the possibilities of their use in lower genital tract diseases |
|
|
Denisova E.D., Apolikhina I.A., Bulgakova N.N., Denisova E.D., Apolikhina I.A., Bulgakova N.N.
|
| No 1 (2019) |
Fluorescence hysteroresectoscopy in the clarifying diagnosis of early endometrial cancer |
|
|
Pronin S.M., Matsneva I.A., Maltsagov M.R.
|
| No 3 (2016) |
FMR1 GENE POLYMORPHISM IN POLYCYSTIC OVARY SYNDROME |
|
|
Tabeeva G.I., Nemova Y.I., Naidukova A.A., Kuznetsova E.B., Zaletaev D.B., Chernukha G.E.
|
| No 6 (2014) |
FOLIC ACID DOSAGE BEFORE, DURING, AND AFTER PREGNANCY: TO DOT THE I'S AND CROSS THE T'S |
|
|
GROMOVA O.A., LIMANOVA O.A., TORSHIN I.Y., KERIMKULOVA N.V., RUDAKOVA K.V.
|
| No 12 (2022) |
Follitropin delta in IVF/ICSI programs |
|
|
Krasnopolskaya K.V., Isakova K.M., Ershova I.Y., Shostenko L.V., Shishkina A.V.
|
| No 7-2 (2011) |
FOLLOW-UP OF PREGNANT WOMEN THROUGH NONINVASIVE SCREENING PROGRAMS |
|
|
BAKHAREV V.A., KARETNIKOVA N.A., STYGAR A.M., EKIMOVA E.V., KOLODKO V.G.
|
| No 10 (2020) |
For the first time in Russia: delivery of twins in patient with premature ovarian insufficiency after a onestage surgical procedure for activation of ovarian function |
|
|
Adamyan L.V., Dementyeva V.O., Asaturova A.V., Stepanian A.A., Smolnikova V.Y., Arakelyan A.S., Gus A.I., Nikolaeva A.V.
|
| No 2 (2010) |
Formally dynamic properties of psyche during normal pregnancy |
|
|
Savchenkov Y.I., Petrosyan E.Y., Savchenkov Y.I., Petrosyan Y.Y.
|
| No 3 (2009) |
Formation of neonatal skin microbiocenosis as a factor for reducing the incidence of pyoseptic diseases |
|
|
Sergevnin V.I., Sharipova I.S., Avdeeva N.S., Markovich N.I., Balkova O.Y., Nizhegorodova L.V., Shatova L.M., Savelova A.M., Sergevnin V.I., Sharipova I.S., Avdeyeva N.S., Markovich N.I., Balkova O.Y., Nizhegorodova L.V., Shatova L.M., Savelova A.M.
|
| No 3 (2013) |
FORMATION OF UNIFIED LEGAL PRINCIPLES OF REPRODUCTIVE HEALTH CARE LEGISLATION IN THE COUNTRIES OF THE COMMONWEALTH OF INDEPENDENT STATES |
|
|
MURZABAYEVA S.S., PAVLOVA Y.V.
|
| No 2 (2019) |
Free amino acid imbalances in amniotic fluid in preeclampsia |
|
|
Pogorelova T.N., Gunko V.O., Palieva N.V., Alliluev I.A., Kaushanskaya L.V., Larichkin A.V.
|
| No 6 (2012) |
FREE EMBRYONIC DNA IN PLASMA AS A PREDICTOR OF SPONTANEOUS PREGNANCY LOSSES IN WOMEN WITH RECURRENT MISCARRIAGE |
|
|
FEDOROVA N.I., TETRUASHVILI N.K., FAIZULLIN L.Z., KARNAUKHOV V.N., SUKHIKH G.T.
|
| No 6 (2014) |
FREE EMBRYONIC DNA IN THE PREDICTION OF PREGNANCY OUTCOME IN OBSTETRIC PATHOLOGY |
|
|
PARSADANYAN N.G., SHUBINA E.S., TROFIMOV D.Y., TETRUASHVILI N.K.
|
| No 4 (2015) |
FREE EMBRYONIC DNA LEVELS IN A PATIENT WITH RECURRENT MISCARRIAGE AND SEVERE PLACENTAL INSUFFICIENCY |
|
|
Parsadanyan N.G., Shubina E.S., Tetruashvili N.K., Agadzanova A.A., Trophimov D.Y.
|
| No 2 (2015) |
FREE EMBRYONIC DNA LEVELS IN THREATENED RECURRENT MISCARRIAGE AND UNCOMPLICATED PREGNANCY AT LESS THAN 22 WEEKS' GESTATION |
|
|
Parsadanyan N.G., Shubina E.S., Tetruashvili N.K., Trofimov D.Y., Sukhikh G.T.
|
| No 5 (2009) |
Frequency of progesterone antibodies in sporadic spontaneous abortion |
|
|
Mandrykina Z.A., Menzhinskaya I.V., Ozerova R.I., Rora L.S., Dobrokhotova Y.E.
|
| No 5 (2021) |
Full-term abdominal pregnancy |
|
|
Ivanova N.A., Kormakova T.L., Ukvalberg M.E., Lazareva A.A., Shvedkina N.N.
|
| No 7 (2018) |
Fulminant massive obstetric hemorrhage in the second trimester of pregnancy in the presence of uterine arteriovenous malformation and placenta increta |
|
|
Belokrinitskaya T.E., Deikova E.Z., Goncharova M.A., Filippov O.S.
|
| No 11 (2022) |
Functional disorders of the liver in the first trimester of pregnancy |
|
|
Kryshnia M.A., Mozgovaya E.V.
|
| No 5 (2022) |
Functional hypothalamic amenorrhea in clinical practice: medical and diagnostic features |
|
|
Bondarenko K.R., Kazantseva V.D., Dobrokhotova Y.E.
|
| No 10 (2016) |
FUNCTIONAL MAGNETIC RESONANCE IMAGING FOR THE DETERMINATION OF BLOOD FLOW IN SYMMETRIC UTERINE ANOMALIES |
|
|
Makiyan Z.N., Adamyan L.V., Bychenko V.G., Miroshnikova N.A., Kozlova A.V.
|
| No 5 (2017) |
Functional magnetic resonance imaging in gynecology |
|
|
Miroshnikova N.A., Bychenko V.G., Adamyan L.V., Kozlova A.V., Makiyan Z.N.
|
| No 11 (2019) |
Functional state of the reproductive system in women of late fertility age |
|
|
Omarova K.M., Ibragimova E.S., Gereikhanova E.G., Magomedova I.K.
|
| No 5 (2017) |
Galina A. Ushakova |
|
|
- -.
|
| No 5 (2018) |
Galina M. Savelyeva |
|
|
- -.
|
| No 7 (2021) |
Gam-COVID-Vac (Sputnik V) vaccine has no adverse effect on ovarian reserve in reproductive-age women |
|
|
Dolgushina N.V., Drapkina Y.S., Krechetova L.V., Ivanets T.Y., Menzhinskaya I.V., Gus A.I., Bayramova G.R., Sukhikh G.T.
|
| No 7 (2021) |
Gam-COVID-Vac (Sputnik V) vaccine has no adverse effect on spermatogenesis in men |
|
|
Drapkina Y.S., Dolgushina N.V., Shatylko T.V., Nikolaeva M.A., Menzhinskaya I.V., Ivanets T.Y., Krechetova L.V., Krasnyi A.M., Gamidov S.I., Bairamova G.R., Sukhikh G.T.
|
| No 1 (2019) |
Gastric carcinoma with ovarian metastases under the mask of pregnancy pathology |
|
|
Kuznetsov P.A., Tyagunova A.V., Olenev A.S., Dzhokhadze L.S., Seliverstova O.M., Dobrokhotova Y.E.
|
| No 1 (2011) |
GASTROSCHISIS: PROBLEMS, FIRST EXPERIENCE, ALGORITHM FOR MEDICAL TACTICS |
|
|
Khamatknanova E.M., Kucherov Y.I., Podurovskaya Y.L., Dorofeyeva E.I., Zhirkova Y.V.
|
| No 3 (2024) |
Gene expression features in patients with genital prolapse |
|
|
Cheremin M.M., Smolnova T.Y., Krasnyi A.M., Chuprynin V.D.
|
| No 12 (2019) |
Gene methylation in the placenta of fetuses with fetal growth restriction |
|
|
Khachatryan Z.V., Kan N.E., Krasnyi A.M., Sadekova A.A., Kurevlev S.V., Tyutyunnik V.L.
|
| No 4 (2014) |
Gene polymorphism as a predictor of recurrent pregnancy losses |
|
|
Alegina E.V., Tetruashvili N.K., Agadzhanova A.A., Trofimov D.Y., Donnikov A.E.
|
| No 2 (2015) |
GENE POLYMORPHISM FOR CATECHOLAMINE METABOLIC ENZYMES AND DNA EXCISION REPAIR AS A PREDICTOR OF REPRODUCTIVE LOSSES |
|
|
Makarov O.V., Morozova K.V., Salnikova L.E., Hadzieva M.B., Goncharova V.S., Lutsenko N.N.
|
| No 7 (2023) |
Gene transcription profiles in fibrocystic breast disease |
|
|
Burmenskaya O.V., Kometova V.V., Smetnik A.A., Rodionov V.V., Trofimov D.Y., Ashrafyan L.A., Sukhikh G.T.
|
| No 11 (2021) |
Genes involved in premature ovarian failure |
|
|
Chernukha G.E., Tabeeva G.I., Rshtuni S.D., Mashaeva R.I., Chernykh V.B., Marchenko L.A.
|
| No 8 (2019) |
GENETIC AND EPIGENETIC MECHANISMS OF GENITAL ENDOMETRIOSIS-ASSOCIATED INFERTILITY |
|
|
Melkozerova O.A., Bashmakova N.V., Okulova E.O.
|
| No 4 (2023) |
Genetic determinants of adenomyosis |
|
|
Malysheva O.V., Yarmolinskaya M.I.
|
| No 4 (2017) |
Genetic factors in the development of recurrent miscarriage: An overview of the data of meta-analyses |
|
|
Trifonova E.A., Ganzha O.A., Gabidulina T.V., Devyatyarova L.L., Sotnikova L.S., Stepanov V.A.
|
| No 12 (2020) |
Genetic predictors of necrotizing enterocolitis in neonates |
|
|
Nikitina I.V., Donnikov A.E., Krogh-Jensen O.A., Krasheninnikova R.V., Nepsha O.S., Lenyushkina A.A., Degtyarev D.N.
|
| No 5 (2016) |
GENETIC PREDISPOSITION TO SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN AN IVF PROGRAM IN A PATIENT WITH A NORMAL OVARIAN RESPONSE: A CLINICAL CASE |
|
|
Strelchenko D.A., Perminova S.G., Donnikov A.E., Saveleva E.M.
|
| No 2 (2012) |
GENETIC RISK FACTORS FOR OBSTETRIC COMPLICATIONS OF SPONTANEOUS OR ASSISTED REPRODUCTIVE TECHNOLOGY PREGNANCY |
|
|
ALEKSANDROVA N.V., DONNIKOV A.E., BAYEV O.R., SUKHIKH G.T.
|
| No 5 (2009) |
Genital candidiasis in the pattern of opportunistic vaginal infections. The principles of laboratory diagnosis and the value of monitoring of fungal susceptibility to antimycotics |
|
|
Ankirskaya A.S., Muravyeva V.V., Mironova T.G., Koroleva T.Y., Lyubasovskaya L.A., Karapetyan T.E., Bairamova G.R.
|
| No 12 (2017) |
Genital herpes: diagnosis, suppressive therapy relevance, prevention |
|
|
Enkova E.V.
|
| No 4-1 (2012) |
GENITAL INFECTIOUS AND INFLAMMATORY DISEASES IN CHILDREN AND ADOLESCENTS |
|
|
ADAMYAN L.V., SIBIRSKAYA E.V., GLYBINA T.M., BOGDANOVA E.A.
|
| No 3 (2012) |
GENITAL PROLAPSE AND THE STATE OF URINARY SYSTEM ORGANS |
|
|
NECHIPORENKO A.N., PRUDKO A.Y., NECHIPORENKO N.A.
|
| No 10 (2018) |
Genital prolapse: a look at the problem |
|
|
Smolnova T.Y., Chuprynin V.D.
|
| No 3 (2023) |
Genital prolapse: Experience in surgical treatment |
|
|
Miklin O.P., Dyshlovaya A.V., Rumyantseva Z.S., Gudz O.V., Yermachkova P.A., Kravchenko A.N., Sulima A.N., Reznichenko N.A., Anikin S.S.
|
| No 6 (2016) |
Genital prolapse: Genetic aspects |
|
|
Lukyanova D.M., Smolnova T.Y., Adamyan L.V.
|
| No 7 (2016) |
Genital prolapse: Genetic aspects |
|
|
Plieva Y.Z., Bobkova M.V., Baranova E.E.
|
| No 12 (2015) |
GENITAL TRACT BLEEDING IN PRESCHOOL GIRLS. RHABDOMYOSARCOMA OF THE VAGINA |
|
|
Batyrova Z.K., Uvarova E.V., Kogan E.A., Kumykova Z.H.
|
| No 3/1S (2019): Supplement |
GENITAL'NYY GERPES. DIAGNOSTIKA I LEChENIE |
|
|
PRILEPSKAYa V.N., ABAKAROVA P.R., DOVLETKhANOVA E.R., MEZhEVITINOVA E.A.
|
| No 12S (2020): Supplement |
GENITOURINARNYY MENOPAUZAL'NYY SINDROM: SOVREMENNYE PODKhODY K DIAGNOSTIKE I LEChENIYu |
|
|
Apolikhina I.A., Yureneva S.V., Malyshkina D.A.
|
| No 11 (2016) |
GENITOURINARY DISORDERS AFTER COMBINED AND COMPLEX TREATMENT FOR CANCER OF THE FEMALE REPRODUCTIVE ORGANS |
|
|
Suvorova V.A., Dobrokhotova Y.E., Ilyina I.Y., Venediktova M.G., Sarantsev A.N., Morozova K.V.
|
| 1201 - 1400 of 3861 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 > >> |
